$DVAX
DYNAVAX TECHNOLOGIES CORP

2020 Q2 Form 10-Q Financial Statement

#000156459020037730 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $2.668M $8.301M $5.773M
YoY Change -67.86% 561.96% 3398.79%
Cost Of Revenue $1.170M $4.440M $4.070M
YoY Change -73.65% -11200.0% 1885.37%
Gross Profit $1.500M $3.860M $1.700M
YoY Change -61.14% 199.22% -4350.0%
Gross Profit Margin 56.22% 46.5% 29.45%
Selling, General & Admin $18.95M $17.86M $18.35M
YoY Change 6.12% 14.11% 8.63%
% of Gross Profit 1263.6% 462.72% 1079.29%
Research & Development $5.884M $16.20M $21.21M
YoY Change -63.67% -0.47% 11.81%
% of Gross Profit 392.27% 419.59% 1247.65%
Depreciation & Amortization $1.250M $3.800M $3.970M
YoY Change -67.11% 21.02% 22.53%
% of Gross Profit 83.33% 98.45% 233.53%
Operating Expenses $24.84M $47.27M $18.35M
YoY Change -47.46% 19.98% -52.32%
Operating Profit -$23.34M -$38.97M -$37.85M
YoY Change -40.11% 2.16% -1.2%
Interest Expense $4.732M $4.598M $2.734M
YoY Change 2.91% 70.87% 135.49%
% of Operating Profit
Other Income/Expense, Net -$111.0K -$123.0K $181.0K
YoY Change -9.76% -151.04% -181.17%
Pretax Income -$51.58M -$42.71M -$39.67M
YoY Change 20.77% 8.29% 1.82%
Income Tax
% Of Pretax Income
Net Earnings -$51.58M -$42.71M -$39.67M
YoY Change 20.76% 8.29% 1.83%
Net Earnings / Revenue -1933.25% -514.55% -687.2%
Basic Earnings Per Share -$0.53 -$0.62
Diluted Earnings Per Share -$0.53 -$656.2K -$0.62
COMMON SHARES
Basic Shares Outstanding 97.34M 63.78M
Diluted Shares Outstanding 97.34M 63.78M

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.7M $140.5M $183.2M
YoY Change 42.85% -34.96% -26.95%
Cash & Equivalents $60.49M $34.23M $112.1M
Short-Term Investments $140.2M $106.3M $71.10M
Other Short-Term Assets $9.500M $6.700M $5.900M
YoY Change 41.79% 71.79% 78.79%
Inventory $54.39M $36.63M $27.57M
Prepaid Expenses
Receivables $900.0K $7.600M $5.800M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $265.5M $191.5M $222.5M
YoY Change 38.68% -15.4% -12.88%
LONG-TERM ASSETS
Property, Plant & Equipment $58.30M $34.39M $58.80M
YoY Change 69.51% 112.3% 244.59%
Goodwill $2.131M
YoY Change
Intangibles $7.147M $9.445M
YoY Change -49.39%
Long-Term Investments
YoY Change
Other Assets $3.400M $1.799M $3.700M
YoY Change 88.99% -33.37% 94.74%
Total Long-Term Assets $63.80M $75.63M $74.10M
YoY Change -15.64% 101.15% 85.7%
TOTAL ASSETS
Total Short-Term Assets $265.5M $191.5M $222.5M
Total Long-Term Assets $63.80M $75.63M $74.10M
Total Assets $329.3M $267.1M $296.6M
YoY Change 23.3% 1.21% 0.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.700M $11.23M $11.90M
YoY Change -75.95% 240.18% 417.39%
Accrued Expenses $18.60M $19.55M $23.90M
YoY Change -4.86% 28.62% 67.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.20M $44.57M $42.25M
YoY Change 19.35% 74.8% 79.79%
LONG-TERM LIABILITIES
Long-Term Debt $179.7M $176.6M $175.7M
YoY Change 1.73% 76.99% 77.09%
Other Long-Term Liabilities $1.910M $643.0K $441.0K
YoY Change 197.05% -91.19% -93.42%
Total Long-Term Liabilities $1.910M $177.3M $176.1M
YoY Change -98.92% 65.53% 66.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.20M $44.57M $42.25M
Total Long-Term Liabilities $1.910M $177.3M $176.1M
Total Liabilities $271.0M $256.5M $253.4M
YoY Change 5.66% 93.43% 95.86%
SHAREHOLDERS EQUITY
Retained Earnings -$1.283B -$1.149B -$1.106B
YoY Change 11.7%
Common Stock $1.343B $1.161B $1.151B
YoY Change 15.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.30M $10.59M $43.16M
YoY Change
Total Liabilities & Shareholders Equity $329.3M $267.1M $296.6M
YoY Change 23.3% 1.21% 0.44%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$51.58M -$42.71M -$39.67M
YoY Change 20.76% 8.29% 1.83%
Depreciation, Depletion And Amortization $1.250M $3.800M $3.970M
YoY Change -67.11% 21.02% 22.53%
Cash From Operating Activities -$21.82M -$36.36M -$39.90M
YoY Change -39.99% 7.16% 33.58%
INVESTING ACTIVITIES
Capital Expenditures -$690.0K -$7.500M $3.882M
YoY Change -90.8% 913.51% 332.78%
Acquisitions
YoY Change
Other Investing Activities -$48.70M -$34.53M $25.50M
YoY Change 41.04% -223.67% -151.73%
Cash From Investing Activities -$49.38M -$42.02M $14.61M
YoY Change 17.52% -254.6% -124.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $13.62M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 93.48M 350.0K 88.26M
YoY Change 26608.57% -391.67% -10.69%
NET CHANGE
Cash From Operating Activities -21.82M -36.36M -39.90M
Cash From Investing Activities -49.38M -42.02M 14.61M
Cash From Financing Activities 93.48M 350.0K 88.26M
Net Change In Cash 22.28M -78.03M 62.78M
YoY Change -128.55% 1035.81% 561.62%
FREE CASH FLOW
Cash From Operating Activities -$21.82M -$36.36M -$39.90M
Capital Expenditures -$690.0K -$7.500M $3.882M
Free Cash Flow -$21.13M -$28.86M -$43.78M
YoY Change -26.78% -13.05% 42.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8301000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13587000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27871000
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M9D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y11M1D
CY2020Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1248000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1394000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
36231000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1910000
CY2020Q2 us-gaap Liabilities
Liabilities
271019000
us-gaap Costs And Expenses
CostsAndExpenses
90899000
us-gaap Operating Income Loss
OperatingIncomeLoss
-42651000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37402000
CY2019Q2 us-gaap Interest Expense
InterestExpense
4598000
us-gaap Costs And Expenses
CostsAndExpenses
56238000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-38971000
us-gaap Operating Income Loss
OperatingIncomeLoss
-76825000
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
979000
us-gaap Investment Income Interest
InvestmentIncomeInterest
921000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1714000
us-gaap Interest Expense
InterestExpense
9463000
us-gaap Interest Expense
InterestExpense
7332000
us-gaap Sublease Income
SubleaseIncome
3853000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36209000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17861000
us-gaap Restructuring Charges
RestructuringCharges
8777000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
47272000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-23339000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
331000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
93467000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4088000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
480000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-51579000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
139000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
83871000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83871000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14074000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16196000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10537000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-144000
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
25655000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
109000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1343279000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2095000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1282998000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58295000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
329314000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5884000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18954000
CY2019Q2 us-gaap Restructuring Charges
RestructuringCharges
8777000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
26007000
CY2020Q2 us-gaap Interest Expense
InterestExpense
4732000
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
1927000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17045000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-111000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-123000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
211000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000
us-gaap Net Income Loss
NetIncomeLoss
-82385000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.28
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
64436000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
176000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
32000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-82353000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11824000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2020Q2 dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
14000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58295000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8290000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
13000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
311000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
107696000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5866000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
292000
us-gaap Net Income Loss
NetIncomeLoss
-64174000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58295000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
43159000
CY2019Q2 dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
19000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
326000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9349000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
448000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-42713000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
10588000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
63065000
dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
1000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
407000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13949000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15519000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
32000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
10588000
us-gaap Net Income Loss
NetIncomeLoss
-64174000
us-gaap Net Income Loss
NetIncomeLoss
-82385000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2063000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3196000
dvax Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1261000
dvax Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
2046000
dvax Gain On Disposal Of Property And Equipment And Lease Termination
GainOnDisposalOfPropertyAndEquipmentAndLeaseTermination
76000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
78000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
875000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17045000
us-gaap Share Based Compensation
ShareBasedCompensation
5866000
us-gaap Share Based Compensation
ShareBasedCompensation
15519000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
2500000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
4570000
dvax Non Cash Interest Expense
NonCashInterestExpense
1726000
dvax Non Cash Interest Expense
NonCashInterestExpense
2135000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-908000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-7983000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
3878000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13060000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17607000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2083000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
643000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-163000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3177000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3993000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2817000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
1383000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
761000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3355000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3574000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48687000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76263000
dvax Payments To Acquire Technology Licenses
PaymentsToAcquireTechnologyLicenses
7000000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
217000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6920000
dvax Payments To Acquire Technology Licenses
PaymentsToAcquireTechnologyLicenses
7000000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
103182000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
108341000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
74400000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
99310000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3038000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11383000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38820000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27414000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
74250000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
107697000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13949000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
13000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
1000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
311000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
407000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
108021000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
88607000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-44000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20602000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15114000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49967000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60702000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34853000
us-gaap Interest Paid Net
InterestPaidNet
7757000
us-gaap Interest Paid Net
InterestPaidNet
5300000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-908000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-3228000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
124000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
34807000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
200700000
CY2020Q2 dvax Secured Long Term Debt Noncurrent Plus Interest In Kind
SecuredLongTermDebtNoncurrentPlusInterestInKind
180900000
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-12-31
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Management’s estimates are based on historical information available as of the date of the condensed consolidated financial statements and various other assumptions we believe are reasonable under the circumstances. However, the worldwide spread of COVID-19 has resulted in a global slowdown of economic activity which is likely to decrease demand for a broad variety of goods and services, while also disrupting sales channels and marketing activities for an unknown period of time until the disease is contained. We are unable to predict the future effect resulting from the COVID-19 pandemic. Actual results could differ materially from management’s estimates.</p>
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2020Q2 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60485000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39884000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34225000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49348000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
216000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
628000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
619000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60702000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40100000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34853000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49967000
CY2020Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
200444000
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
278000
CY2020Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
200708000
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
150983000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
84000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12000
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
151055000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
117285000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
117551000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
22674000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
22672000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
139959000
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
140223000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
24981000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15198000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
21649000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
22890000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7762000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3244000
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
14000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2020Q2 us-gaap Inventory Net
InventoryNet
54392000
CY2019Q4 us-gaap Inventory Net
InventoryNet
41332000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19773000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19773000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19773000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17273000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2500000
CY2020Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
200000
CY2019Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
2300000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
2500000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
4600000
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1561000
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1747000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3153000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3485000
us-gaap Operating Lease Payments
OperatingLeasePayments
3400000
us-gaap Operating Lease Payments
OperatingLeasePayments
2400000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3045000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3039000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
36231000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37845000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
39276000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
40884000
CY2020Q2 dvax Lessor Sublease Rentals Payments To Be Received Remainder Of Fiscal Year
LessorSubleaseRentalsPaymentsToBeReceivedRemainderOfFiscalYear
2553000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3443000
CY2020Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Two
LessorSubleaseRentalsPaymentsToBeReceivedDueYearTwo
5201000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6898000
CY2020Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Three
LessorSubleaseRentalsPaymentsToBeReceivedDueYearThree
5357000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6214000
CY2020Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Four
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFour
5518000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5353000
CY2020Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Five
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFive
5684000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5497000
CY2020Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Thereafter
LessorSubleaseRentalsPaymentsToBeReceivedDueThereafter
39595000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
36299000
CY2020Q2 dvax Lessor Sublease Rentals Payments To Be Received Due
LessorSubleaseRentalsPaymentsToBeReceivedDue
63908000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
63704000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24428000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
39276000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M24D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y8M12D
CY2018Q2 dvax Increase In Number Of Employee Stock Purchase Plan Shares Authorized For Issuance
IncreaseInNumberOfEmployeeStockPurchasePlanSharesAuthorizedForIssuance
600000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
12626000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5151000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.29
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1168000
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2020Q2 us-gaap Purchase Obligation
PurchaseObligation
10100000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.66
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.64
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21257000
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10950000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21257000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10950000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
139000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
278000000
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109503242
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18525000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
12.72
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8006000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.86
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1574000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.36
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.74
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9196000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.52
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13445000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8932000
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
4088000
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
9349000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5866000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
15519000
CY2019Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
80
CY2019Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.36
CY2019Q2 us-gaap Restructuring Charges
RestructuringCharges
8800000
CY2019Q2 us-gaap Restructuring And Related Activities Completion Date
RestructuringAndRelatedActivitiesCompletionDate
2019-12-31
CY2019Q4 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
13400000

Files In Submission

Name View Source Status
0001564590-20-037730-index-headers.html Edgar Link pending
0001564590-20-037730-index.html Edgar Link pending
0001564590-20-037730.txt Edgar Link pending
0001564590-20-037730-xbrl.zip Edgar Link pending
dvax-10q_20200630.htm Edgar Link pending
dvax-10q_20200630_htm.xml Edgar Link completed
dvax-20200630.xsd Edgar Link pending
dvax-20200630_cal.xml Edgar Link unprocessable
dvax-20200630_def.xml Edgar Link unprocessable
dvax-20200630_lab.xml Edgar Link unprocessable
dvax-20200630_pre.xml Edgar Link unprocessable
dvax-ex101_118.htm Edgar Link pending
dvax-ex102_119.htm Edgar Link pending
dvax-ex103_185.htm Edgar Link pending
dvax-ex311_9.htm Edgar Link pending
dvax-ex312_8.htm Edgar Link pending
dvax-ex321_7.htm Edgar Link pending
dvax-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending